Cloeckaert A, Jacques I, Bowden R A, Dubray G, Limet J N
Institut National de la Recherche Agronomique, Centre de Recherches de Tours, Nouzilly, France.
Res Microbiol. 1993 Jul-Aug;144(6):475-84. doi: 10.1016/0923-2508(93)90055-7.
We characterized 4 monoclonal antibodies (mAb) specific for rough lipopolysaccharide (R-LPS) of Brucella. mAb were selected by enzyme-linked immunosorbent assay (ELISA) on whole B. abortus 45/20 rough cells and R-LPS from B. melitensis B115 rough cells. Specificity was confirmed by immunoblot analysis using R-LPS and smooth LPS (S-LPS) preparations. Anti-R-LPS revealed the low molecular mass R-LPS molecules below 20.1 kDa in the R-LPS and S-LPS preparations as well as the typical A and M patterns in high molecular mass S-LPS molecules (between 21.5 and 66 kDa) in the S-LPS preparations. An O-polysaccharide-specific mAb revealed only high molecular mass S-LPS molecules in the S-LPS preparation. In ELISA the anti-R-LPS mAb bound better on rough than on smooth B. abortus 544 whole cells, and this was confirmed by immunoelectron microscopy. Protective activity of anti-R-LPS mAb of different isotypes was tested on mice and compared with an S-LPS-specific mAb. Only the IgG3 mAb reduced significantly the splenic infection but did not reach the level of protection conferred by the S-LPS-specific mAb.
我们鉴定了4种对布鲁氏菌粗糙脂多糖(R-LPS)具有特异性的单克隆抗体(mAb)。通过酶联免疫吸附测定(ELISA),在流产布鲁氏菌45/20粗糙型全菌细胞以及来自羊布鲁氏菌B115粗糙型细胞的R-LPS上筛选mAb。使用R-LPS和平滑脂多糖(S-LPS)制剂通过免疫印迹分析确认特异性。抗R-LPS抗体在R-LPS和S-LPS制剂中显示出低于20.1 kDa的低分子量R-LPS分子,以及在S-LPS制剂中高分子量S-LPS分子(21.5至66 kDa之间)中的典型A和M模式。一种O-多糖特异性mAb仅在S-LPS制剂中显示出高分子量S-LPS分子。在ELISA中,抗R-LPS mAb与粗糙型流产布鲁氏菌544全菌细胞的结合优于光滑型,这通过免疫电子显微镜得到证实。在小鼠上测试了不同亚型的抗R-LPS mAb的保护活性,并与一种S-LPS特异性mAb进行比较。只有IgG3 mAb显著降低了脾脏感染,但未达到S-LPS特异性mAb所赋予的保护水平。